Join to View Full Profile
13330 Usf Laurel DrTampa, FL 33612
Phone+1 813-974-2201
Fax+1 813-974-4325
Dr. Hussein is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of MarylandFellowship, Hematology and Medical Oncology, 1986 - 1989
Cleveland Clinic FoundationResidency, Internal Medicine, 1985 - 1986
University of Mississippi Medical CenterResidency, Internal Medicine, 1983 - 1985
Ain Shams University Faculty of MedicineClass of 1981
Certifications & Licensure
FL State Medical License 2007 - 2027
OH State Medical License 1986 - 2026
MD State Medical License 1989 - 1992
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Outgoing Public Health Reporting from EpicCare Functionality, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR (Complete), Allscripts, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
Clinical Trials
- Combination Chemotherapy Following GM-CSF in Treating Patients With Multiple Myeloma Start of enrollment: 1998 Oct 01
- Combination Chemotherapy in Treating Patients With Multiple Myeloma Start of enrollment: 1998 Nov 01
- Rituximab in Treating Patients With Multiple Myeloma Start of enrollment: 1998 Nov 01
Publications & Presentations
PubMed
- 66 citationsDisease and outcome disparities in multiple myeloma: exploring the role of race/ethnicity in the Cooperative Group clinical trialsSikander Ailawadhi, Susanna Jacobus, Rachael Sexton, Alexander Keith Stewart, Angela Dispenzieri
Blood Cancer Journal. 2018-07-06 - 72 citationsThe Role of Minimal Residual Disease Testing in Myeloma Treatment Selection and Drug Development: Current Value and Future Applications.Kenneth C. Anderson, Daniel Auclair, Gary J. Kelloff, Caroline C. Sigman, Hervé Avet-Loiseau
Clinical Cancer Research. 2017-08-01 - Response to letter, ‘Immortal time bias in retrospective analysis’Meletios A. Dimopoulos, Arlene S. Swern, Jack Shiansong Li, Mohamad A. Hussein, Lilia Weiss
Blood Cancer Journal. 2015-07-31
Press Mentions
Starton Therapeutics Advances STAR-LLD Transdermal Lenalidomide Following Successful Skin Permeation StudiesJune 9th, 2021- Drs. Kenneth Anderson and Asher Chanan-Khan to Join Starton Therapeutics Board of DirectorsSeptember 9th, 2020
- ChemioCare Strengthens Its Proposed Slate of Directors with the Nomination of Multiple Myeloma Expert Dr. Mohamad HusseinOctober 7th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
